List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 251 studies with search of: Malaysia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
2 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
3 Completed CUTE (Chronic Urticaria Treatment Evaluation)
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Levocetirizine;   Drug: Desloratadine
4 Active, not recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone
5 Recruiting Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fluorouracil (5-FU)
6 Recruiting Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Placebo;   Drug: RGH-188;   Drug: RGH-188;   Drug: RGH-188;   Drug: Risperidone
7 Completed Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.
Condition: Chronic Renal Failure
Intervention: Device: Baxter’s UltraBag® and FMC Andy·Disc®
8 Recruiting Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBF 1120;   Drug: placebo;   Drug: pemetrexed
9 Completed Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)
Condition: COPD
Interventions: Drug: Roflumilast;   Drug: Placebo
10 Completed 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
Conditions: Diabetic Nephropathies;   Hypertension
Interventions: Drug: Telmisartan;   Drug: Valsartan
11 Completed Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept , Methotrexate;   Drug: Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide
12 Completed MICHELANGELO OASIS-6 : FOndaparinux in ST Elevation Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: fondaparinux sodium;   Drug: heparin;   Drug: Glucose-insulin-potassium (GIK)
13 Completed Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Conditions: Hypertension;   Hyperlipidemia
Intervention: Drug: Amlodipine/atorvastatin single pill
14 Recruiting Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
Condition: Hypertension
Intervention: Drug: Amlodipine besylate/atorvastatin calcium single pill combination
15 Recruiting Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: PHX1149T;   Drug: PHX1149T;   Drug: Placebo
16 Active, not recruiting Efficacy and Safety of BI 1356 Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: placebo
17 Active, not recruiting Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
Conditions: Chronic Kidney Disease;   End-Stage Renal Failure;   Anaemia
Intervention: Drug: Biogeneric Epoetin
18 Active, not recruiting First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Carboplatin;   Drug: Paclitaxel
19 Active, not recruiting A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Interventions: Drug: Talaporfin sodium;   Device: Interstitial Light Emitting Diodes;   Procedure: Percutaneous placement of device in the liver;   Procedure: Standard Care
20 Not yet recruiting Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
Conditions: Hyperparathyroidism;   Kidney Disease
Interventions: Drug: Paricalitol;   Drug: Calcitriol

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services